"The amount of data obtained are overwhelming and will need careful interpretation due to the study's significant implications, which may change the way adjuvant anticoagulation is given to ACS ...
KANSAS CITY, MO — In a large observational study of patients who had nonelective PCI for ACS, those who received a glycoprotein IIb/IIIa inhibitor (GPI) had a lower risk of all-cause in-hospital ...
NEW ORLEANS, LA—A single subcutaneous injection of a novel, small-molecule glycoprotein IIb/IIIa inhibitor administered at first medical contact in patients with suspected STEMI improves the patency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback